Earth Science Tech (ETST) Research & Development (2011 - 2023)

Earth Science Tech's (ETST) quarterly Research & Development came in at $6817.0 in Q2 2023, down 24.26% on a QoQ basis from $9000.0 in Q2 2020.

Earth Science Tech (ETST) Research & Development (2011 - 2023) Analysis & Trends

Earth Science Tech (ETST) has 9 years of Research & Development data on file, last reported at $6817.0 in Q2 2023.

Quarterly Research & Development changed N/A year-over-year to $6817.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $6817.0 (changed N/A YoY) and the FY2023 annual result came in at $8074.0, up 120.9% from the prior year.
Research & Development declined to $6817.0 in Q2 2023, from $9000.0 in the prior quarter.
In the past five years, Research & Development ranged from a high of $32857.0 in Q1 2019 to a low of $6817.0 in Q2 2023.
A 3-year average of $17826.7 and a median of $18000.0 in 2019 frame the typical range for Research & Development.
The widest YoY moves for Research & Development: up 37.85% in 2019, down 86.81% in 2019.
Tracing ETST's Research & Development over 3 years: stood at $18000.0 in 2019, then slumped by 50.0% to $9000.0 in 2020, then dropped by 24.26% to $6817.0 in 2023.
The last three Research & Development figures came in at $6817.0 (Q2 2023), $9000.0 (Q2 2020), and $18000.0 (Q1 2020), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	R&D (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-	-
2	Teva Pharmaceutical Industries	43.28 Bn	39.62 Bn	2.15 Bn	970.00 Mn
3	Zoetis	31.79 Bn	30.11 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.69 Bn	22.89 Bn	5.10 Bn	-1.05 Bn
5	United Therapeutics	22.25 Bn	19.58 Bn	683.80 Mn	146.30 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	248.30 Mn
7	Neurocrine Biosciences	15.58 Bn	15.19 Bn	935.80 Mn	326.70 Mn
8	Elanco Animal Health	11.87 Bn	11.34 Bn	798.00 Mn	92.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	-
10	Earth Science Tech	31.63 Mn	28.84 Mn	6.28 Mn	-

Download Data